Education
About Us
Working with TipRanks
Follow Us
Zhaoke Ophthalmology Ltd. (HK:6622)
:6622
6622 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$1.20 - HK$2.23
Previous CloseN/A
Volume310.50K
Average Volume (3M)3.03M
Market Cap
HK$1.06B
Enterprise Value-HK$717.50M
Total Cash (Recent Filing)-¥238.49M
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)―
Beta1.12
Next Earnings
Aug 20, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.47
Shares Outstanding546,139,160
10 Day Avg. Volume2,403,563
30 Day Avg. Volume3,029,486
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$2.50Price Target Upside36.61% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
---
Zhaoke Ophthalmology Ltd. News
PremiumCompany Announcements
Zhaoke Ophthalmology Makes Strides with Myopia Drug
PremiumCompany Announcements
Zhaoke Ophthalmology Reports Positive Trial Results for TAB014PremiumCompany Announcements
Zhaoke Ophthalmology Expands Glaucoma Drug Portfolio
PremiumCompany Announcements
Zhaoke Ophthalmology Reports Success in Myopia Trial
PremiumCompany Announcements
Zhaoke Ophthalmology Completes Major Drug Trial
PremiumCompany Announcements
Zhaoke Ophthalmology Launches Preservative-Free Glaucoma Drug
PremiumCompany Announcements
Zhaoke Ophthalmology Narrows Losses in 2024---
6622 FAQ
What was Zhaoke Ophthalmology Ltd.’s price range in the past 12 months?
Zhaoke Ophthalmology Ltd. lowest stock price was HK$1.20 and its highest was HK$2.23 in the past 12 months.
What is Zhaoke Ophthalmology Ltd.’s market cap?
Zhaoke Ophthalmology Ltd.’s market cap is HK$1.06B.
When is Zhaoke Ophthalmology Ltd.’s upcoming earnings report date?
Zhaoke Ophthalmology Ltd.’s upcoming earnings report date is Aug 20, 2025 which is in 143 days.
How were Zhaoke Ophthalmology Ltd.’s earnings last quarter?
Zhaoke Ophthalmology Ltd. released its earnings results on Mar 24, 2025. The company reported -HK$0.321 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.321.
Is Zhaoke Ophthalmology Ltd. overvalued?
According to Wall Street analysts Zhaoke Ophthalmology Ltd.’s price is currently Undervalued.
Does Zhaoke Ophthalmology Ltd. pay dividends?
Zhaoke Ophthalmology Ltd. does not currently pay dividends.
What is Zhaoke Ophthalmology Ltd.’s EPS estimate?
Zhaoke Ophthalmology Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zhaoke Ophthalmology Ltd. have?
Zhaoke Ophthalmology Ltd. has 546,139,160 shares outstanding.
What happened to Zhaoke Ophthalmology Ltd.’s price movement after its last earnings report?
Zhaoke Ophthalmology Ltd. reported an EPS of -HK$0.321 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.878%.
Which hedge fund is a major shareholder of Zhaoke Ophthalmology Ltd.?
Currently, no hedge funds are holding shares in HK:6622
---
Zhaoke Ophthalmology Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
23.49%
12-Months-Change
Fundamentals
Return on Equity
-12.04%
Trailing 12-Months
Asset Growth
-10.40%
Trailing 12-Months
Company Description
Zhaoke Ophthalmology Ltd.
Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company, engages in the research, development, and commercialization of therapies that address unmet medical needs in the People's Republic of China. It is developing various drugs that cover ophthalmic indications affecting the anterior and posterior segments, including dry eye diseases, wet age-related macular degeneration, diabetic macular edema, myopia, and glaucoma. The company was formerly known as China Ophthalmology Focus Limited. Zhaoke Ophthalmology Limited was incorporated in 2017 and is headquartered in Guangzhou, the People's Republic of China.
---
6622 Stock 12 Month Forecast
Average Price Target
HK$2.50
▲(36.61% Upside)
Technical Analysis
Sino Biopharmaceutical
―
CSPC Pharmaceutical Group
―
Livzon Pharmaceutical Group
―
Wuxi Biologics (Cayman)
―
Viva Biotech Holdings
―
Best Analysts Covering 6622
1 Year
Unknown AnalystJefferies
Not Ranked
1 Year Success Rate
0/0 ratings generated profit
1 Year Average Return
0.00%
reiterated a buy rating 5 months ago
Copying Unknown Analyst's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
---